The secondary prevention of myocardial infarction

Current Problems in Cardiology

Volumn 24, Issue 10, 1999, Pages 622-677

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; ANTILIPEMIC AGENT; ANTIOXIDANT; ANTITHROMBOCYTIC AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; FOLIC ACID; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LISINOPRIL; METOPROLOL; NIFEDIPINE; NITRIC ACID DERIVATIVE; OXPRENOLOL; PROPRANOLOL; RAMIPRIL; TIMOLOL; TRANDOLAPRIL; UNINDEXED DRUG; VERAPAMIL; VITAMIN B GROUP; WARFARIN; ZOFENOPRIL;

CLINICAL TRIAL; DEFIBRILLATOR; DEPRESSION; DIET THERAPY; HEART INFARCTION; HEART REHABILITATION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; LIFESTYLE; META ANALYSIS; REVIEW; SECONDARY PREVENTION; SMOKING CESSATION;

EID: 85044493953     PISSN: 01462806     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0146-2806(99)90010-5     Document Type: Review

References (35)

1. American Heart Association. Heart and stroke facts: 1996 statistical supplement. Dallas: American Heart Association; 1996. p. 1-23.
2. Moss AJ, Benhorin J. Prognosis and management after a first myocardial infarction. N Engl J Med 1990;322:743-53.
3. Hinstridge V, Speight TM. An overview of therapeutic interventions in myocardial infarction: emphasis on secondary prevention. Drugs 1991;42 (suppl 2):8-20.
4. Siegel D, Grady D, Browner WS, Hulley SB. Risk factor modification after myocardial infarction. Ann Intern Med 1988;109:213-8.
5. Deedwania PC, Carbajal EV. Secondary prevention after myocardial infarction: too many choices, which ones work? [Editorial.] Arch Intern Med 1993; 153:285-8.
6. Deedwania PC, Amsterdam EA, Vagelos RH. Evidence-based, cost-effective risk stratification and management after myocardial infarction. California Cardiology Working Group on Post-MI Management. Arch Intern Med 1997;157:273-80.
7. Winslow E, Bohannon N, Brunton SA, Mayhew HE. Lifestyle modification: weight control, exercise, and smoking cessation. Am J Med 1996;101(suppl 4A):25S-31S.
8. Rogot E, Murray JL. Smoking and causes of death among U.S. veterans: 16 years of observation. Public Health Rep 1980;95:213-22.
9. Ronnevik PK, Gundersen T, Abrahamsen AM. Effect of smoking habits and timolol treatment on mortality and reinfarction in patients surviving acute myocardial infarction. Br Heart J 1985;54:134-9.
10. Sperry RE, Vacek JL, Smith GS. The effects of smoking on the signal-averaged electocardiogram in normal subjects. Chest 1991;99:121-2.
11. Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 1990;80:954-8.
12. Ockene IS, Ockene JK. Smoking after acute myocardial infarction: a good thing? {Editorial.} Heart Dis Stroke 1993;2:271-3.
13. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313:1511-4.
14. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl Med 1990;322:213-7.
15. Dobson AJ, Alexander HM, Heller RF, Lloyd DM. How soon after quitting smoking does risk of heart attach decline? J Clin Epidemiol 1991;44:1247-53.
16. Cavender JB, Rogers WJ, Fisher LD, Gersh BJ, Coggin CJ, Myers WO. Effects of smoking on survival and morbidity in patients randomized to medical or surgical therapy in the Coronary Artery Surgery Study (CASS): 10-year follow-up. CASS Investigators. J Am Coll Cardiol 1992;20:287-94.
17. Jafri SM, Tilley BC, Peters R, Schultz LR, Goldstein S. Effects of cigarette smoking and propranolol in survivors of acute myocardial infarction. Am J Cardiol 1990;65:271-6.
18. Kannel WB, Thomas HE Jr. Sudden coronary death: the Framingham Study. Ann N Y Acad Sci 1982;382:3-21.
19. Hallstrom AP, Cobb LA, Ray R. Smoking as a risk factor for recurrence of sudden cardiac arrest. N Engl J Med 1986;314:271-5.
20. Rivers JT, White HD, Cross DB, Williams BF, Noms RM. Reinfarction after thrombolytic therapy for acute myocardial infarction followed by conservative management: incidence and effect of smoking. J Am Coll Cardiol 1990;16:340-8.
21. Rigotti NA, Singer DE, Mulley AG Jr, Thibault GE. Smoking cessation following admission to a coronary care unit. J Gen Intern Med 1991;6:305-11.
22. Krumholz HM, Cohen BJ, Tsevat J, Pasternak RC, Weinstein MC. Cost-effectiveness of a smoking cessation program after myocardial infarction. J Am Coll Cardiol 1993;22:1697-702.
23. Ockene J, Kristeller JL, Goldberg R, Ockene I, Merriam P, Barrett S, et al. Smoking cessation and severity of disease: the Coronary Artery Smoking Intervention Study. Health Psychol 1992;11:119-26.
24. Henningfield JE. Nicotine medications for smoking cessation. N Engl J Med 1995;333:1196-203.
25. Ziegelstein RC, Fauerbach JA, Richter DP, Sordo SS, Bush DE. Post-myocardial infarction depression: an additive and independent predictor of 4 month mortality [abstract]. Circulation 1997;96(suppl I): 1-341.
26. Frasure-Smith N, Lesperance F, Talajic M. Depression following myocardial infarction: impact on 6-month survival. JAMA 1993;270:1819-25.
27. Frasure-Smith N, Lesperance F, Talajic M. Depression and 18-month prognosis after myocardial infarction. Circulation 1995;91:999-1005.
28. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction: a prospective, population-based study of the elderly. Ann Intern Med 1992;117:1003-9.
29. Bucher HC. Social support and prognosis following first myocardial infarction. J Gen Intern Med 1994;9:409-17.
30. Moser DK, Dracup K. Is anxiety early after myocardial infarction associated with subsequent ischemic and arrhythmic events [abstract]. Circulation 1997;92(suppl I):1-10.
31. Denollet J, Sys SU, Stroobant N, Rombouts H, Gillebert TC, Brutsaert DL. Personality as independent predictor of long-term mortality in patients with coronary heart disease. Lancet 1996;347:417-21.
32. Denollet J, Brutsaert DL. Personality, disease severity, and the risk of long-term cardiac events in patients with a decreased ejection fraction after myocardial infarction. Circulation 1998;97:167-73.
33. Wilhelmsson C, Vedin JA, Elmfeldt D, Tibblin G, Wilhelmsen L. Hypertension and myocardial infarction. J Chronic Dis 1978;31:157-64.
34. Kannel WB, Sorlie P, Castelli WP, McGee D. Blood pressure and survival after myocardial infarction: the Framingham study. Am J Cardiol 1980;45:326-30.
35. Blood pressure in survivors of myocardial infarction. The Coronary Drug Project Research Group. J Am Coll Cardiol 1984;4:1135-47.